PET Imaging in Animal Models of Alzheimer's Disease

The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for detection of these hallmarks of Alzheimer's disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD characte...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 16; p. 872509
Main Authors Chen, Baosheng, Marquez-Nostra, Bernadette, Belitzky, Erika, Toyonaga, Takuya, Tong, Jie, Huang, Yiyun, Cai, Zhengxin
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 24.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for detection of these hallmarks of Alzheimer's disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD characterization and have become an integral part of ongoing clinical trials to screen patients for enrollment, prove drug action mechanisms, and monitor therapeutic effects. Meanwhile, preclinical PET imaging in animal models of AD can provide supportive information for mechanistic studies. With the recent advancement of gene editing technologies and AD animal model development, preclinical PET imaging in AD models will further facilitate our understanding of AD pathogenesis/progression and the development of novel treatments. In this study, we review the current state-of-the-art in preclinical PET imaging using animal models of AD and suggest future research directions.
AbstractList The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for detection of these hallmarks of Alzheimer's disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD characterization and have become an integral part of ongoing clinical trials to screen patients for enrollment, prove drug action mechanisms, and monitor therapeutic effects. Meanwhile, preclinical PET imaging in animal models of AD can provide supportive information for mechanistic studies. With the recent advancement of gene editing technologies and AD animal model development, preclinical PET imaging in AD models will further facilitate our understanding of AD pathogenesis/progression and the development of novel treatments. In this study, we review the current state-of-the-art in preclinical PET imaging using animal models of AD and suggest future research directions.
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these hallmarks of Alzheimer’s disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD characterization and have become an integral part of ongoing clinical trials to screen patients for enrollment, prove drug action mechanisms, and monitor therapeutic effects. Meanwhile, preclinical PET imaging in animal models of AD can provide supportive information for mechanistic studies. With the recent advancement of gene editing technologies and AD animal model development, preclinical PET imaging in AD models will further facilitate our understanding of AD pathogenesis/progression and the development of novel treatments. In this study, we review the current state-of-the-art in preclinical PET imaging using animal models of AD and suggest future research directions.
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these hallmarks of Alzheimer’s disease (AD) antemortem. Amyloid and tau PET have been incorporated into the A/T/N scheme for AD characterization and have become an integral part of ongoing clinical trials to screen patients for enrollment, prove drug action mechanisms, and monitor therapeutic effects. Meanwhile, preclinical PET imaging in animal models of AD can provide supportive information for mechanistic studies. With the recent advancement of gene editing technologies and AD animal model development, preclinical PET imaging in AD models will further facilitate our understanding of AD pathogenesis/progression and the development of novel treatments. In this study, we review the current state-of-the-art in preclinical PET imaging using animal models of AD and suggest future research directions.
Author Chen, Baosheng
Cai, Zhengxin
Belitzky, Erika
Huang, Yiyun
Marquez-Nostra, Bernadette
Toyonaga, Takuya
Tong, Jie
AuthorAffiliation PET Center, Radiology, Yale School of Medicine , New Haven, CT , United States
AuthorAffiliation_xml – name: PET Center, Radiology, Yale School of Medicine , New Haven, CT , United States
Author_xml – sequence: 1
  givenname: Baosheng
  surname: Chen
  fullname: Chen, Baosheng
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 2
  givenname: Bernadette
  surname: Marquez-Nostra
  fullname: Marquez-Nostra, Bernadette
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 3
  givenname: Erika
  surname: Belitzky
  fullname: Belitzky, Erika
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 4
  givenname: Takuya
  surname: Toyonaga
  fullname: Toyonaga, Takuya
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 5
  givenname: Jie
  surname: Tong
  fullname: Tong, Jie
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 6
  givenname: Yiyun
  surname: Huang
  fullname: Huang, Yiyun
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
– sequence: 7
  givenname: Zhengxin
  surname: Cai
  fullname: Cai, Zhengxin
  organization: PET Center, Radiology, Yale School of Medicine, New Haven, CT, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35685772$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1PGzEQhi1EVT7aH8AF7Q0uSf39cUGKgLaRQPQAEjfL6x0Ho10b7ASp_fXdEIjg5JFn5plXeg7QbsoJEDoieMqYNj9CiqlOKaZ0qhUV2OygfSIlnXDB7ne3Ndd76KDWR4wl1Zx-RXtMSC2UovuI_bm8beaDW8S0aGJqZikOrm-ucwd9bXJoZv2_B4gDlJPaXMQKrsI39CW4vsL3t_cQ3f28vD3_Pbm6-TU_n11NPNPYTKQKuIV2PC-8CxqToAxI6dvASBckFYwI1fmWcE07EExK3XJujOuUaJWU7BDNN9wuu0f7VMZk5a_NLtrXj1wW1pVl9D3YVnngUmkSmOCcGKeI0EGaDjsqiHMj62zDelq1A3Qe0rK4_hP0cyfFB7vIL9YQRZjiI-D0DVDy8wrq0g6xeuh7lyCvqqVSCYklpuvcZDPqS661QNieIdiuxdlXcXYtzm7EjTvHH_NtN95Nsf-D4ZUT
CitedBy_id crossref_primary_10_3389_fphy_2023_1303690
crossref_primary_10_1021_acsptsci_3c00213
Cites_doi 10.1073/pnas.96.21.11872
10.1016/j.neuroimage.2021.118302
10.1523/JNEUROSCI.1202-06.2006
10.1016/j.pscychresns.2021.111354
10.1016/S1474-4422(17)30343-5
10.2967/jnumed.116.187625
10.1016/j.cell.2019.09.001
10.1016/j.jalz.2012.11.008
10.1002/ajmg.b.32499
10.1186/s13024-019-0333-5
10.1002/alz.12328
10.1016/S1474-4422(17)30159-X
10.1523/JNEUROSCI.22-21-09340.2002
10.1371/journal.pone.0031310
10.2967/jnumed.117.201632
10.1002/ana.24394
10.1016/j.proghi.2016.01.001
10.2174/187152708784936653
10.1177/1536012120947582
10.1111/cns.12720
10.2353/ajpath.2007.070403
10.1016/j.neuroscience.2003.08.007
10.1001/archneurol.2009.46
10.1016/j.neurobiolaging.2017.05.008
10.4061/2011/810981
10.1002/cne.24741
10.1002/ajp.23254
10.3233/JAD-160572
10.1016/j.neulet.2018.07.038
10.1111/j.1471-4159.2012.07908.x
10.1186/s40478-016-0300-0
10.1007/s00401-007-0312-8
10.1242/dmm.026120
10.2967/jnumed.113.132068
10.1523/JNEUROSCI.2990-05.2005
10.1177/0271678X211031035
10.1016/j.neuint.2011.11.005
10.1007/s10495-010-0463-2
10.1007/s00259-019-04305-8
10.1016/s0092-8674(00)80244-5
10.3233/jad-2004-6301
10.1007/s00259-005-1780-5
10.1186/s13024-020-00409-0
10.1016/S1474-4422(15)70016-5
10.1016/j.jalz.2017.11.005
10.1016/j.brainres.2013.10.003
10.1021/bi061359o
10.3390/molecules25040982
10.1126/science.1113694
10.2967/jnumed.112.110163
10.1016/j.nbd.2004.10.013
10.1007/s00259-018-4012-5
10.1016/j.neuron.2011.04.009
10.3389/fnins.2019.00043
10.1016/j.neurobiolaging.2007.10.006
10.1016/j.bbapap.2010.04.001
10.1186/s13195-020-00702-6
10.4172/2161-0460.1000160
10.1038/s41380-018-0108-3
10.1016/j.neuron.2009.06.026
10.2967/jnumed.111.088815
10.1126/scitranslmed.aaf6667
10.1093/brain/awu064
10.1007/s00401-013-1231-5
10.1177/0271678X16677990
10.3389/fnagi.2018.00425
10.1016/j.arr.2016.01.002
10.1007/s11248-009-9245-4
10.3390/ph14111179
10.1016/j.neuropharm.2021.108676
10.1073/pnas.89.10.4471
10.1186/1471-2202-9-28
10.1016/j.nbd.2014.05.001
10.1186/s13024-018-0280-6
10.1177/1536012117704557
10.1016/0304-3940(94)90589-4
10.1007/s11307-020-01567-9
10.1002/ana.20009
10.1523/JNEUROSCI.0858-11.2011
10.1007/s11307-018-1167-1
10.2967/jnumed.115.169078
10.1016/j.neurobiolaging.2010.08.005
10.2174/1570159X13666150716165726
10.1016/j.nucmedbio.2012.03.001
10.1073/pnas.94.24.13287
10.1007/s11307-009-0198-z
10.1016/j.neuron.2013.07.037
10.3233/JAD-170591
10.3389/fnins.2019.00735
10.1177/0271678X16645593
10.1007/s00259-021-05597-5
10.1111/bpa.12893
10.1089/neu.2012.2449
10.3389/fphys.2019.00838
10.1097/NEN.0b013e3182814cdf
10.2119/2003-00044.herrera
10.1073/pnas.1714966115
10.1021/jm401184f
10.7150/thno.56059
10.1016/j.bbr.2007.08.003
10.3233/JAD-122068
10.1038/78078
10.3233/JAD-160763
10.1007/s11910-019-0962-7
10.1016/j.bbr.2008.05.008
10.2174/1567205011666140505111354
10.2967/jnumed.120.249144
10.1038/s41583-018-0054-8
10.1016/j.jalz.2018.06.2855
10.3389/fnins.2019.00604
10.3389/fnagi.2021.624330
10.1523/JNEUROSCI.2880-19.2020
10.1073/pnas.1812155116
10.1097/WNR.0000000000000811
10.3389/fnins.2017.00626
10.1177/0271678X211004146
10.1093/brain/awr038
10.1021/acschemneuro.0c00802
10.3390/molecules25071750
10.1111/j.1582-4934.2009.00809.x
10.1016/j.neuroimage.2003.07.002
10.1124/pr.109.002451
10.1016/j.jcpa.2010.11.004
10.1002/glia.22289
10.1016/j.bmc.2010.05.058
10.1371/journal.pone.0069830
10.1093/hmg/ddx366
10.3390/ijms20010081
10.2967/jnumed.113.136143
10.1007/s00259-019-04399-0
10.1021/acschemneuro.8b00526
10.3389/fnagi.2018.00174
10.1038/373523a0
10.1523/JNEUROSCI.4236-05.2006
10.2967/jnumed.115.163493
10.1523/JNEUROSCI.3672-12.2013
10.1126/science.1062097
10.1038/369488a0
10.3389/fnagi.2021.735524
10.3390/diagnostics11101874
10.1016/j.nucmedbio.2016.03.004
10.1016/j.celrep.2017.06.023
10.1016/j.nbd.2020.104811
10.1186/s12967-016-0901-1
10.1006/nbdi.1999.0279
10.1186/1742-2094-10-90
10.1007/s11307-018-01313-2
10.3389/fnagi.2021.767322
10.1177/1536012115624920
10.1038/nm.4443
10.1073/pnas.2034101100
10.1111/j.1582-4934.2009.00781.x
10.1186/s40035-017-0093-5
10.1016/j.neurobiolaging.2011.09.026
10.3233/JAD-160408
10.3233/JAD-160760
10.1016/s1389-0344(01)00067-3
10.4049/jimmunol.0803612
10.1186/s13195-015-0158-6
10.1002/syn.21842
10.1007/BF01972876
10.1038/sj.jcbfm.9600146
10.1016/j.trci.2017.08.004
10.1016/s0166-4328(01)00232-7
10.1016/j.neurobiolaging.2010.10.015
10.1016/j.neurobiolaging.2012.12.027
10.1038/npp.2011.31
10.1186/s40478-015-0258-3
10.1007/s11011-010-9207-9
10.3233/JAD-2010-1349
10.2967/jnumed.121.263281
10.1007/s11307-015-0833-9
10.2967/jnumed.115.168179
10.1016/j.nbd.2009.09.004
10.2967/jnumed.117.197608
10.1186/s13195-017-0253-y
10.3389/fnins.2022.787404
10.1016/j.neurobiolaging.2019.08.006
10.3233/JAD-150824
10.1016/j.bbr.2016.05.012
10.1038/s41380-018-0342-8
10.2967/jnumed.118.209916
10.1242/jcs.114.6.1179
10.2217/bmm.09.92
10.1038/85064
10.1002/j.1460-2075.1995.tb07116.x
10.1002/alz.12318
10.1016/j.neuropharm.2016.10.009
10.3390/ijms17091447
10.1021/acschemneuro.0c00790
10.1186/s40478-015-0252-9
10.1053/j.semnuclmed.2020.12.004
10.3389/fmed.2019.00071
10.1007/s00259-019-04419-z
10.1097/00019442-200201000-00004
10.1016/S0140-6736(20)32205-4
10.3233/JAD-2011-0008
10.1002/cne.23877
10.1002/alz.12325
10.1038/ncomms10759
10.1002/alz.12192
10.1093/braincomms/fcaa058
10.1007/s11307-021-01591-3
10.1021/acs.jmedchem.9b01406
10.1073/pnas.1912954116
10.1523/JNEUROSCI.4251-12.2013
10.1038/s41598-019-42286-8
10.3389/fimmu.2021.739130
10.1177/1536012115624919
10.1021/acs.molpharmaceut.7b00235
10.1007/s11307-018-1260-5
10.1007/s00259-020-05149-3
10.2967/jnumed.118.223867
10.1038/ncb1901
10.3233/JAD-170509
10.3233/JAD-201146
10.3233/JAD-200287
10.1074/jbc.RA119.009487
10.3390/ijms17101707
10.1016/j.neuroimage.2018.10.011
10.1038/s41598-019-41443-3
10.2967/jnumed.118.222034
10.1007/s00259-019-04559-2
10.1038/82868
10.1016/j.neuroscience.2004.07.036
10.1212/WNL.0000000000006075
10.3389/fnins.2020.00810
10.1097/NEN.0000000000000230
10.1523/JNEUROSCI.0673-07.2007
10.1523/JNEUROSCI.1738-05.2005
10.1212/01.wnl.0000259035.98480.ed
10.1016/j.nbd.2014.08.032
10.1007/s00259-019-04357-w
10.1046/j.1471-4159.2003.01879.x
10.1021/ml500285t
10.1093/hmg/ddh019
ContentType Journal Article
Copyright Copyright © 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai.
Copyright © 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai. 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai
Copyright_xml – notice: Copyright © 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai.
– notice: Copyright © 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai. 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fnins.2022.872509
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed


CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1662-453X
EndPage 872509
ExternalDocumentID oai_doaj_org_article_b7ce46781f354419a7158f69d0a251aa
10_3389_fnins_2022_872509
35685772
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: R01AG058773; R01AG069921
GroupedDBID ---
29H
2WC
53G
5GY
5VS
88I
8FE
8FH
9T4
AAFWJ
ABUWG
ACGFO
ACGFS
ACXDI
ADRAZ
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
C1A
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EMOBN
F5P
FRP
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IEA
IHR
ISR
KQ8
LK8
M2P
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RNS
RPM
W2D
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c3809-67f0beb5485caf801f79e66cbf31df6253157dcb1482de53668b4499ad75b7663
IEDL.DBID RPM
ISSN 1662-4548
1662-453X
IngestDate Tue Oct 22 15:12:03 EDT 2024
Tue Sep 17 21:13:54 EDT 2024
Sat Oct 26 00:00:40 EDT 2024
Mon Sep 16 17:15:40 EDT 2024
Sat Sep 28 08:19:12 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Alzheimer’s disease
neuroinflamamation
SV2A
neurodegeneration
tau
animal model
positron emission tomography
β-amyloid (Aβ)
Language English
License Copyright © 2022 Chen, Marquez-Nostra, Belitzky, Toyonaga, Tong, Huang and Cai.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3809-67f0beb5485caf801f79e66cbf31df6253157dcb1482de53668b4499ad75b7663
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
Edited by: Ruiqing Ni, ETH Zürich, Switzerland
Reviewed by: Nicolas Tournier, Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), France; Steven Liang, Massachusetts General Hospital and Harvard Medical School, United States
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171374/
PMID 35685772
PQID 2675606026
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_b7ce46781f354419a7158f69d0a251aa
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9171374
proquest_miscellaneous_2675606026
crossref_primary_10_3389_fnins_2022_872509
pubmed_primary_35685772
PublicationCentury 2000
PublicationDate 2022-05-24
PublicationDateYYYYMMDD 2022-05-24
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-24
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in neuroscience
PublicationTitleAlternate Front Neurosci
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Tran (B209) 2011; 31
Brendel (B28) 2018; 10
Sturchler-Pierrat (B199) 1997; 94
Sehlin (B188) 2016; 7
Xu (B227) 2015; 3
Nishiyama (B155) 2015; 69
Xia (B224) 2013; 9
Chiaravalloti (B35) 2018; 20
Harada (B84) 1994; 369
Snellman (B197) 2017; 57
Sun (B201) 2017; 23
Long (B128) 2019; 179
Naj (B149) 2017; 174
Li (B121) 2021; 48
Avila (B10) 2017; 11
Peeraer (B162) 2015; 73
Bao (B15) 2021; 13
Rabinovici (B169) 2007; 68
Fan (B61) 2016; 57
Tucker (B211) 2001; 4
Takkinen (B203) 2017; 37
McMurray (B139) 2021; 12
Herreman (B88) 1999; 96
Sanz (B185) 2009; 182
Snellman (B196) 2013; 54
Rojas (B173) 2013; 34
Guehl (B79) 2019; 46
Heneka (B87) 2006; 26
Wang (B216) 2005; 18
Jackson (B97) 2019; 13
Price (B166) 2005; 25
He (B85) 2018; 24
Echeverria (B56); 6
Rodriguez-Vieitez (B171) 2017; 37
Heneka (B86) 2015; 14
Li (B123); 46
Bacskai (B11) 2003; 100
Chambers (B32) 2015; 3
Laforce (B114) 2018; 14
Allen (B3) 2002; 22
Meier (B140) 2021; 23
(B5) 2021; 17
Arnsten (B7); 17
Wolfe (B222) 2018; 20
Senechal (B189) 2008; 186
Marutle (B137) 2013; 10
Yu (B232) 2012; 29
Paspalas (B161) 2018; 14
Shen (B191) 1997; 89
Wang (B218) 2017; 57
Jankowsky (B101) 2001; 17
Sanabria Bohórquez (B182) 2019; 46
Sancheti (B183) 2013; 8
Schmidt (B187) 2015; 74
Choi (B37) 2012; 60
Dumanis (B54) 2013; 124
Ferreira-Vieira (B64) 2016; 14
Klunk (B107) 2004; 55
Haque (B83) 2019; 116
Kang (B103) 2018; 27
Li (B125) 2016; 17
Chaney (B33) 2021; 11
Li (B122); 10
Leuzy (B118) 2019; 24
Lopresti (B130) 2005; 46
Sala (B181) 2020; 47
Waldron (B215) 2017; 55
Ji (B102) 2003; 122
Traynelis (B210) 2010; 62
Shin (B193) 2011; 26
Xiang (B225) 2018; 13
Sadasivam (B178) 2021; 23
Warnock (B220) 2014; 55
Duff (B53) 2000; 7
Jakobsen (B99) 2016; 53
Wang (B219) 2019; 19
Weng (B221) 2020; 25
Kuntner (B113) 2009; 11
Saito (B180) 2019; 294
Sadasivam (B179) 2019; 39
Wong (B223) 2018; 59
Rowe (B174) 2021; 316
Maruyama (B138) 2013; 79
Rubinski (B175) 2020; 12
Ni (B153) 2021; 14
Prpar Mihevc (B167) 2019; 13
Toyama (B206) 2005; 32
Pini (B164) 2016; 30
Okamura (B158) 2014; 137
Abey (B1) 2021; 31
Ryan (B177) 2010; 4
Fang (B62) 2017; 113
Benedikz (B18) 2009; 13
Charreau (B34) 1996; 5
Ojo (B157) 2013; 72
Waldron (B214); 7
Götz (B75) 2018; 19
Estrada (B59) 2016; 43
Nabulsi (B146) 2019; 60
Cohen (B41) 2014; 72
Cai (B30) 2014; 55
Macdonald (B132) 2014; 11
Morris (B144) 2011; 70
Tauber (B204) 2013; 36
Toyonaga (B207) 2022; 16
Varlow (B212) 2020; 25
Duyckaerts (B55) 2008; 115
Bouter (B24) 2019; 6
Lewandowski (B119) 2020; 139
Baker (B13) 2016; 4
Frisoni (B72) 2017; 16
Filipcik (B65) 2012; 33
Constantinescu (B45) 2019; 21
Aschenbrenner (B9) 2018; 91
Coleman (B43) 2017; 16
Zheng (B235) 2022; 49
Rohn (B172) 2010; 15
Cai (B31) 2019; 691
Zhou (B237) 2021; 41
Chotipanich (B38) 2020; 19
Hung (B94) 2016; 51
Kaufman (B104) 2015; 77
Zhu (B238) 2012; 60
Kragh (B112) 2009; 18
Maeda (B133) 2007; 27
Beckman (B17) 2021; 17
Ordonez-Gutierrez (B160) 2016; 54
Scheltens (B186) 2021; 397
Murugan (B145) 2019; 46
Klunk (B108) 2005; 25
Horti (B90) 2010; 18
Tong (B205) 2020; 63
Okamura (B159) 2005; 25
Poisnel (B165) 2012; 33
Querol-Vilaseca (B168) 2019; 9
Condello (B44) 2018; 115
Cohen (B42) 2013; 33
Bolmont (B22) 2007; 171
Lewis (B120) 2000; 25
Maeda (B134) 2007; 46
Deleye (B51) 2017; 58
Shoghi-Jadid (B194) 2002; 10
Wang (B217) 2016; 51
Becker (B16) 2017; 14
Martin (B136) 2019; 24
Srivastava (B198) 2020; 78
Su (B200) 2020; 76
Ikonomovic (B95) 2009; 66
Games (B73) 1995; 373
Melnikova (B141) 2013; 33
Knight (B109) 2021; 12
Kotredes (B110) 2021; 13
Alzghool (B4) 2021; 196
Chiotis (B36) 2018; 45
Ellenbroek (B58) 2016; 9
Bour (B23) 2008; 193
Grueninger (B78) 2010; 37
Lee (B115) 2019; 84
Flood (B68) 2009; 30
Andorfer (B6) 2003; 86
Halliday (B81) 2017; 16
Ng (B152) 2017; 9
Ettrup (B60) 2011; 52
Moreno-Gonzalez (B143) 2021; 11
Shaw (B190) 2001; 124
Lopez-Picon (B129) 2018; 59
Haque (B82) 2008; 7
Ishikawa (B96) 2018; 61
Kim (B105) 2009; 63
Yi (B230) 2020; 2
Li (B124) 2010; 25
Gotz (B77) 1995; 14
Biancalana (B21) 2010; 1804
Cai (B29) 2001; 4
Naganawa (B148) 2021; 62
Jankowsky (B100) 2004; 13
Declercq (B49) 2016; 15
Bouter (B25) 2018; 10
Liu (B126) 2019; 13
Santacruz (B184) 2005; 309
DeTure (B52) 2019; 14
Hoffe (B89) 2019; 10
Piedrahita (B163) 1992; 89
Clavaguera (B39) 2009; 11
Fiock (B67) 2020; 528
Gao (B74) 2013; 56
Lo Sasso (B127) 2016; 14
Bahri (B12) 2017; 3
Waldron (B213); 17
Datta (B47) 2021; 17
Braak (B26) 1994; 171
Fodero-Tavoletti (B69) 2012; 39
Zhao (B234) 2019; 9
Shimojo (B192) 2020; 40
Toyonaga (B208) 2019; 60
Leslie (B117) 2021; 13
Luo (B131) 2012; 33
Foster (B71) 2017; 322
Manook (B135) 2012; 7
Yaghmoor (B228) 2014; 4
Jadhav (B98) 2020; 15
Kloskowska (B106) 2010; 14
Fang (B63) 2019; 184
Hu (B93) 2020; 14
Smolek (B195) 2016; 524
Tai (B202) 2011; 2011
Arnsten (B8); 83
Gotz (B76) 2001; 293
Nabulsi (B147) 2016; 57
Neustadtl (B151) 2017; 28
Brendel (B27) 2016; 57
Xiong (B226) 2021; 239
Clavaguera (B40) 2014; 127
Finnema (B66) 2016; 8
Zhou (B236) 2021; 12
Beyer (B20) 2021; 51
Berdyyeva (B19) 2019; 21
Leon (B116) 2010; 20
Oakley (B156) 2006; 26
Dawson (B48) 2001; 114
Baker (B14) 2021; 41
Agca (B2) 2008; 9
Das (B46) 2017; 6
Rocher (B170) 2003; 20
Echeverria (B57); 129
Haas (B80) 2017; 20
Yu (B231) 2011; 145
Horti (B91) 2014; 55
Nakaizumi (B150) 2018; 61
Horti (B92) 2019; 116
Ni (B154) 2018; 59
Ruiz-Opazo (B176) 2004; 10
Koutseff (B111) 2014; 1542
More (B142) 2016; 17
Yamamoto (B229) 2011; 36
Deleye (B50) 2016; 15
Zeydan (B233) 2021
Fodero-Tavoletti (B70) 2011; 134
References_xml – volume: 96
  start-page: 11872
  year: 1999
  ident: B88
  article-title: Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.96.21.11872
  contributor:
    fullname: Herreman
– volume: 239
  year: 2021
  ident: B226
  article-title: In vivo imaging of synaptic density with [(11)C]UCB-J PET in two mouse models of neurodegenerative disease.
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2021.118302
  contributor:
    fullname: Xiong
– volume: 26
  start-page: 10129
  year: 2006
  ident: B156
  article-title: Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1202-06.2006
  contributor:
    fullname: Oakley
– volume: 316
  year: 2021
  ident: B174
  article-title: Imaging of brain muscarinic receptors with (18)F-Fluorobenzyl-Dexetimide: a first in human study.
  publication-title: Psychiatry Res. Neuroimaging
  doi: 10.1016/j.pscychresns.2021.111354
  contributor:
    fullname: Rowe
– volume: 16
  start-page: 862
  year: 2017
  ident: B81
  article-title: Pathology and hippocampal atrophy in Alzheimer’s disease.
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(17)30343-5
  contributor:
    fullname: Halliday
– volume: 58
  start-page: 1977
  year: 2017
  ident: B51
  article-title: Evaluation of small-animal PET outcome measures to detect disease modification induced by BACE inhibition in a transgenic mouse model of Alzheimer disease.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.116.187625
  contributor:
    fullname: Deleye
– volume: 179
  start-page: 312
  year: 2019
  ident: B128
  article-title: Alzheimer disease: an update on pathobiology and treatment strategies.
  publication-title: Cell
  doi: 10.1016/j.cell.2019.09.001
  contributor:
    fullname: Long
– volume: 9
  start-page: 666
  year: 2013
  ident: B224
  article-title: [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease.
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.jalz.2012.11.008
  contributor:
    fullname: Xia
– volume: 174
  start-page: 5
  year: 2017
  ident: B149
  article-title: Alzheimer’s disease genetics, C. genomic variants, genes, and pathways of Alzheimer’s disease: an overview.
  publication-title: Am. J. Med. Genet. B Neuropsychiatr. Genet.
  doi: 10.1002/ajmg.b.32499
  contributor:
    fullname: Naj
– volume: 14
  year: 2019
  ident: B52
  article-title: The neuropathological diagnosis of Alzheimer’s disease.
  publication-title: Mol. Neurodegener.
  doi: 10.1186/s13024-019-0333-5
  contributor:
    fullname: DeTure
– volume: 17
  start-page: 327
  year: 2021
  ident: B5
  article-title: 2021 Alzheimer’s disease facts and figures.
  publication-title: Alzheimers Dement.
  doi: 10.1002/alz.12328
– volume: 16
  start-page: 661
  year: 2017
  ident: B72
  article-title: Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers.
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(17)30159-X
  contributor:
    fullname: Frisoni
– volume: 22
  start-page: 9340
  year: 2002
  ident: B3
  article-title: Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-21-09340.2002
  contributor:
    fullname: Allen
– volume: 7
  year: 2012
  ident: B135
  article-title: Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s disease.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0031310
  contributor:
    fullname: Manook
– volume: 59
  start-page: 960
  year: 2018
  ident: B154
  article-title: Comparative in vitro and in vivo quantifications of pathologic tau deposits and their association with neurodegeneration in tauopathy mouse models.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.117.201632
  contributor:
    fullname: Ni
– volume: 77
  start-page: 953
  year: 2015
  ident: B104
  article-title: Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24394
  contributor:
    fullname: Kaufman
– volume: 51
  start-page: 1
  year: 2016
  ident: B94
  article-title: Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review.
  publication-title: Prog. Histochem. Cytochem.
  doi: 10.1016/j.proghi.2016.01.001
  contributor:
    fullname: Hung
– volume: 7
  start-page: 270
  year: 2008
  ident: B82
  article-title: New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer’s disease: cathepsin inhibitors as potential therapeutics.
  publication-title: CNS Neurol. Disord. Drug Targets
  doi: 10.2174/187152708784936653
  contributor:
    fullname: Haque
– volume: 19
  year: 2020
  ident: B38
  article-title: Evaluation of imaging windows for Tau PET imaging using 18F-PI2620 in cognitively normal individuals, mild cognitive impairment, and Alzheimer’s disease patients.
  publication-title: Mol. Imaging
  doi: 10.1177/1536012120947582
  contributor:
    fullname: Chotipanich
– volume: 23
  start-page: 748
  year: 2017
  ident: B201
  article-title: Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene.
  publication-title: CNS Neurosci. Ther.
  doi: 10.1111/cns.12720
  contributor:
    fullname: Sun
– volume: 171
  start-page: 2012
  year: 2007
  ident: B22
  article-title: Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2007.070403
  contributor:
    fullname: Bolmont
– volume: 122
  start-page: 305
  year: 2003
  ident: B102
  article-title: Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer’s disease patients.
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2003.08.007
  contributor:
    fullname: Ji
– volume: 66
  start-page: 646
  year: 2009
  ident: B95
  article-title: Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
  publication-title: Arch. Neurol.
  doi: 10.1001/archneurol.2009.46
  contributor:
    fullname: Ikonomovic
– volume: 57
  start-page: 84
  year: 2017
  ident: B197
  article-title: Applicability of [(11)C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2017.05.008
  contributor:
    fullname: Snellman
– volume: 2011
  year: 2011
  ident: B202
  article-title: Introducing human APOE into abeta transgenic mouse models.
  publication-title: Int. J. Alzheimers Dis.
  doi: 10.4061/2011/810981
  contributor:
    fullname: Tai
– volume: 528
  start-page: 108
  year: 2020
  ident: B67
  article-title: beta-amyloid and tau pathology in the aging feline brain.
  publication-title: J. Comp. Neurol.
  doi: 10.1002/cne.24741
  contributor:
    fullname: Fiock
– volume: 83
  ident: B8
  article-title: Studies of aging nonhuman primates illuminate the etiology of early-stage Alzheimer’s-like neuropathology: an evolutionary perspective.
  publication-title: Am. J. Primatol.
  doi: 10.1002/ajp.23254
  contributor:
    fullname: Arnsten
– volume: 54
  start-page: 645
  year: 2016
  ident: B160
  article-title: AbetaPP/PS1 transgenic mice show sex differences in the cerebellum associated with aging.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-160572
  contributor:
    fullname: Ordonez-Gutierrez
– volume: 691
  start-page: 44
  year: 2019
  ident: B31
  article-title: PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases.
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2018.07.038
  contributor:
    fullname: Cai
– volume: 124
  start-page: 4
  year: 2013
  ident: B54
  article-title: APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals.
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2012.07908.x
  contributor:
    fullname: Dumanis
– volume: 4
  year: 2016
  ident: B13
  article-title: A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions.
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-016-0300-0
  contributor:
    fullname: Baker
– volume: 115
  start-page: 5
  year: 2008
  ident: B55
  article-title: Alzheimer disease models and human neuropathology: similarities and differences.
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-007-0312-8
  contributor:
    fullname: Duyckaerts
– volume: 9
  start-page: 1079
  year: 2016
  ident: B58
  article-title: Rodent models in neuroscience research: is it a rat race?
  publication-title: Dis. Model. Mech.
  doi: 10.1242/dmm.026120
  contributor:
    fullname: Ellenbroek
– volume: 55
  start-page: 672
  year: 2014
  ident: B91
  article-title: 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.113.132068
  contributor:
    fullname: Horti
– volume: 25
  start-page: 10598
  year: 2005
  ident: B108
  article-title: Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2990-05.2005
  contributor:
    fullname: Klunk
– volume: 41
  start-page: 3302
  year: 2021
  ident: B14
  article-title: Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X211031035
  contributor:
    fullname: Baker
– volume: 60
  start-page: 68
  year: 2012
  ident: B37
  article-title: Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-kappaB signaling pathway.
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2011.11.005
  contributor:
    fullname: Choi
– volume: 15
  start-page: 1403
  year: 2010
  ident: B172
  article-title: The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities.
  publication-title: Apoptosis
  doi: 10.1007/s10495-010-0463-2
  contributor:
    fullname: Rohn
– volume: 46
  start-page: 1369
  year: 2019
  ident: B145
  article-title: Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-019-04305-8
  contributor:
    fullname: Murugan
– volume: 89
  start-page: 629
  year: 1997
  ident: B191
  article-title: Skeletal and CNS defects in Presenilin-1-deficient mice.
  publication-title: Cell
  doi: 10.1016/s0092-8674(00)80244-5
  contributor:
    fullname: Shen
– volume: 6
  start-page: 209
  ident: B56
  article-title: Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/jad-2004-6301
  contributor:
    fullname: Echeverria
– volume: 32
  start-page: 593
  year: 2005
  ident: B206
  article-title: PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-005-1780-5
  contributor:
    fullname: Toyama
– volume: 15
  year: 2020
  ident: B98
  article-title: Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
  publication-title: Mol. Neurodegener.
  doi: 10.1186/s13024-020-00409-0
  contributor:
    fullname: Jadhav
– volume: 14
  start-page: 388
  year: 2015
  ident: B86
  article-title: Neuroinflammation in Alzheimer’s disease.
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(15)70016-5
  contributor:
    fullname: Heneka
– volume: 14
  start-page: 680
  year: 2018
  ident: B161
  article-title: The aged rhesus macaque manifests Braak stage III/IV Alzheimer’s-like pathology.
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.jalz.2017.11.005
  contributor:
    fullname: Paspalas
– volume: 1542
  start-page: 32
  year: 2014
  ident: B111
  article-title: Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: pathophysiological relevance for Alzheimer’s disease?
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2013.10.003
  contributor:
    fullname: Koutseff
– volume: 46
  start-page: 3856
  year: 2007
  ident: B134
  article-title: Granular tau oligomers as intermediates of tau filaments.
  publication-title: Biochemistry
  doi: 10.1021/bi061359o
  contributor:
    fullname: Maeda
– volume: 25
  year: 2020
  ident: B212
  article-title: Revisiting the radiosynthesis of [(18)F]FPEB and preliminary PET imaging in a mouse model of Alzheimer’s disease.
  publication-title: Molecules
  doi: 10.3390/molecules25040982
  contributor:
    fullname: Varlow
– volume: 309
  start-page: 476
  year: 2005
  ident: B184
  article-title: Tau suppression in a neurodegenerative mouse model improves memory function.
  publication-title: Science
  doi: 10.1126/science.1113694
  contributor:
    fullname: Santacruz
– volume: 54
  start-page: 1434
  year: 2013
  ident: B196
  article-title: Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.112.110163
  contributor:
    fullname: Snellman
– volume: 18
  start-page: 390
  year: 2005
  ident: B216
  article-title: Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2004.10.013
  contributor:
    fullname: Wang
– volume: 45
  start-page: 1605
  year: 2018
  ident: B36
  article-title: Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-018-4012-5
  contributor:
    fullname: Chiotis
– volume: 70
  start-page: 410
  year: 2011
  ident: B144
  article-title: The many faces of tau.
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.04.009
  contributor:
    fullname: Morris
– volume: 13
  year: 2019
  ident: B126
  article-title: The role of NMDA receptors in Alzheimer’s disease.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00043
  contributor:
    fullname: Liu
– volume: 30
  start-page: 1078
  year: 2009
  ident: B68
  article-title: A transgenic rat model of Alzheimer’s disease with extracellular Abeta deposition.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2007.10.006
  contributor:
    fullname: Flood
– volume: 1804
  start-page: 1405
  year: 2010
  ident: B21
  article-title: Molecular mechanism of Thioflavin-T binding to amyloid fibrils.
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbapap.2010.04.001
  contributor:
    fullname: Biancalana
– volume: 12
  year: 2020
  ident: B175
  article-title: Alzheimer’s Disease Neuroimaging, I. FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.
  publication-title: Alzheimers Res. Ther.
  doi: 10.1186/s13195-020-00702-6
  contributor:
    fullname: Rubinski
– volume: 4
  year: 2014
  ident: B228
  article-title: The role of TREM2 in Alzheimer’s disease and other neurological disorders.
  publication-title: J. Alzheimers Dis. Parkinson.
  doi: 10.4172/2161-0460.1000160
  contributor:
    fullname: Yaghmoor
– volume: 24
  start-page: 108
  year: 2019
  ident: B136
  article-title: New role of P2X7 receptor in an Alzheimer’s disease mouse model.
  publication-title: Mol. Psychiatry
  doi: 10.1038/s41380-018-0108-3
  contributor:
    fullname: Martin
– volume: 63
  start-page: 287
  year: 2009
  ident: B105
  article-title: The role of apolipoprotein E in Alzheimer’s disease.
  publication-title: Neuron
  doi: 10.1016/j.neuron.2009.06.026
  contributor:
    fullname: Kim
– volume: 52
  start-page: 1449
  year: 2011
  ident: B60
  article-title: 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.111.088815
  contributor:
    fullname: Ettrup
– volume: 8
  year: 2016
  ident: B66
  article-title: Imaging synaptic density in the living human brain.
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aaf6667
  contributor:
    fullname: Finnema
– volume: 137
  start-page: 1762
  year: 2014
  ident: B158
  article-title: Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET.
  publication-title: QARain
  doi: 10.1093/brain/awu064
  contributor:
    fullname: Okamura
– volume: 127
  start-page: 299
  year: 2014
  ident: B40
  article-title: Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice.
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1231-5
  contributor:
    fullname: Clavaguera
– volume: 37
  start-page: 2870
  year: 2017
  ident: B203
  article-title: Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal (18)F-FDG and (18)F-DPA-714 PET imaging.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X16677990
  contributor:
    fullname: Takkinen
– volume: 10
  year: 2018
  ident: B25
  article-title: (18)F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer’s disease.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2018.00425
  contributor:
    fullname: Bouter
– volume: 30
  start-page: 25
  year: 2016
  ident: B164
  article-title: Brain atrophy in Alzheimer’s disease and aging.
  publication-title: Ageing Res. Rev.
  doi: 10.1016/j.arr.2016.01.002
  contributor:
    fullname: Pini
– volume: 18
  start-page: 545
  year: 2009
  ident: B112
  article-title: Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer’s disease-causing dominant mutation APPsw.
  publication-title: Transgenic Res.
  doi: 10.1007/s11248-009-9245-4
  contributor:
    fullname: Kragh
– volume: 14
  year: 2021
  ident: B153
  article-title: Positron emission tomography in animal models of Alzheimer’s disease amyloidosis: translational implications.
  publication-title: Pharmaceuticals
  doi: 10.3390/ph14111179
  contributor:
    fullname: Ni
– volume: 196
  year: 2021
  ident: B4
  article-title: (S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer’s disease.
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2021.108676
  contributor:
    fullname: Alzghool
– volume: 89
  start-page: 4471
  year: 1992
  ident: B163
  article-title: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.89.10.4471
  contributor:
    fullname: Piedrahita
– volume: 9
  year: 2008
  ident: B2
  article-title: Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer’s disease: transgene and endogenous APP genes are regulated tissue-specifically.
  publication-title: BMC Neurosci.
  doi: 10.1186/1471-2202-9-28
  contributor:
    fullname: Agca
– volume: 72
  start-page: 117
  year: 2014
  ident: B41
  article-title: Early detection of Alzheimer’s disease using PiB and FDG PET.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2014.05.001
  contributor:
    fullname: Cohen
– volume: 13
  year: 2018
  ident: B225
  article-title: The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
  publication-title: Mol. Neurodegener.
  doi: 10.1186/s13024-018-0280-6
  contributor:
    fullname: Xiang
– volume: 16
  year: 2017
  ident: B43
  article-title: Brain and brown adipose tissue metabolism in transgenic Tg2576 mice models of Alzheimer disease assessed using (18)F-FDG PET imaging.
  publication-title: Mol. Imaging
  doi: 10.1177/1536012117704557
  contributor:
    fullname: Coleman
– volume: 171
  start-page: 1
  year: 1994
  ident: B26
  article-title: Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat.
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(94)90589-4
  contributor:
    fullname: Braak
– volume: 23
  start-page: 372
  year: 2021
  ident: B178
  article-title: Quantification of SV2A Binding in Rodent Brain Using [(18)F]SynVesT-1 and PET Imaging.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-020-01567-9
  contributor:
    fullname: Sadasivam
– volume: 55
  start-page: 306
  year: 2004
  ident: B107
  article-title: Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20009
  contributor:
    fullname: Klunk
– volume: 31
  start-page: 9513
  year: 2011
  ident: B209
  article-title: Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0858-11.2011
  contributor:
    fullname: Tran
– volume: 20
  start-page: 659
  year: 2018
  ident: B35
  article-title: Coupled Imaging with [18F]FBB and [18F]FDG in AD subjects show a selective association between amyloid burden and cortical dysfunction in the brain.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-018-1167-1
  contributor:
    fullname: Chiaravalloti
– volume: 57
  start-page: 1753
  year: 2016
  ident: B61
  article-title: Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.169078
  contributor:
    fullname: Fan
– volume: 33
  start-page: 933
  year: 2012
  ident: B131
  article-title: Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer’s disease.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2010.08.005
  contributor:
    fullname: Luo
– volume: 14
  start-page: 101
  year: 2016
  ident: B64
  article-title: Alzheimer’s disease: targeting the cholinergic system.
  publication-title: Curr. Neuropharmacol.
  doi: 10.2174/1570159X13666150716165726
  contributor:
    fullname: Ferreira-Vieira
– volume: 39
  start-page: 1042
  year: 2012
  ident: B69
  article-title: In vitro characterization of [18F]-florbetaben, an Abeta imaging radiotracer.
  publication-title: Nucl. Med. Biol.
  doi: 10.1016/j.nucmedbio.2012.03.001
  contributor:
    fullname: Fodero-Tavoletti
– volume: 94
  start-page: 13287
  year: 1997
  ident: B199
  article-title: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.94.24.13287
  contributor:
    fullname: Sturchler-Pierrat
– volume: 11
  start-page: 236
  year: 2009
  ident: B113
  article-title: Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer’s disease.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-009-0198-z
  contributor:
    fullname: Kuntner
– volume: 79
  start-page: 1094
  year: 2013
  ident: B138
  article-title: Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.07.037
  contributor:
    fullname: Maruyama
– volume: 61
  start-page: 1355
  year: 2018
  ident: B150
  article-title: In vivo depiction of α7 nicotinic receptor loss for cognitive decline in Alzheimer’s disease.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-170591
  contributor:
    fullname: Nakaizumi
– volume: 13
  year: 2019
  ident: B97
  article-title: Targeting the synapse in Alzheimer’s disease.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00735
  contributor:
    fullname: Jackson
– volume: 37
  start-page: 740
  year: 2017
  ident: B171
  article-title: Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer’s disease.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X16645593
  contributor:
    fullname: Rodriguez-Vieitez
– volume: 49
  start-page: 1482
  year: 2022
  ident: B235
  article-title: A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-021-05597-5
  contributor:
    fullname: Zheng
– volume: 31
  start-page: 144
  year: 2021
  ident: B1
  article-title: Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer’s disease and other tauopathies.
  publication-title: Brain Pathol.
  doi: 10.1111/bpa.12893
  contributor:
    fullname: Abey
– volume: 29
  start-page: 2342
  year: 2012
  ident: B232
  article-title: Lithium reduces BACE1 overexpression, beta amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury.
  publication-title: J. Neurotrauma
  doi: 10.1089/neu.2012.2449
  contributor:
    fullname: Yu
– volume: 10
  year: 2019
  ident: B89
  article-title: The use of pigs as a translational model for studying neurodegenerative diseases.
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2019.00838
  contributor:
    fullname: Hoffe
– volume: 72
  start-page: 137
  year: 2013
  ident: B157
  article-title: Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice.
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/NEN.0b013e3182814cdf
  contributor:
    fullname: Ojo
– volume: 10
  start-page: 36
  year: 2004
  ident: B176
  article-title: Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats.
  publication-title: Mol. Med.
  doi: 10.2119/2003-00044.herrera
  contributor:
    fullname: Ruiz-Opazo
– volume: 115
  start-page: E782
  year: 2018
  ident: B44
  article-title: Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer’s disease.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1714966115
  contributor:
    fullname: Condello
– volume: 56
  start-page: 7574
  year: 2013
  ident: B74
  article-title: Derivatives of dibenzothiophene for positron emission tomography imaging of alpha7-nicotinic acetylcholine receptors.
  publication-title: J. Med. Chem.
  doi: 10.1021/jm401184f
  contributor:
    fullname: Gao
– volume: 11
  start-page: 6644
  year: 2021
  ident: B33
  article-title: Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
  publication-title: Theranostics
  doi: 10.7150/thno.56059
  contributor:
    fullname: Chaney
– volume: 186
  start-page: 126
  year: 2008
  ident: B189
  article-title: Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning.
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2007.08.003
  contributor:
    fullname: Senechal
– volume: 36
  start-page: 311
  year: 2013
  ident: B204
  article-title: QARain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer’s disease patients.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-122068
  contributor:
    fullname: Tauber
– volume: 25
  start-page: 402
  year: 2000
  ident: B120
  article-title: Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
  publication-title: Nat. Genet.
  doi: 10.1038/78078
  contributor:
    fullname: Lewis
– volume: 57
  start-page: 1041
  year: 2017
  ident: B218
  article-title: Role of glutamate and NMDA receptors in Alzheimer’s disease.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-160763
  contributor:
    fullname: Wang
– volume: 19
  year: 2019
  ident: B219
  article-title: Tau imaging in neurodegenerative diseases using positron emission tomography.
  publication-title: Curr. Neurol. Neurosci. Rep.
  doi: 10.1007/s11910-019-0962-7
  contributor:
    fullname: Wang
– volume: 193
  start-page: 174
  year: 2008
  ident: B23
  article-title: Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2008.05.008
  contributor:
    fullname: Bour
– volume: 11
  start-page: 450
  year: 2014
  ident: B132
  article-title: Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
  publication-title: Curr. Alzheimer Res.
  doi: 10.2174/1567205011666140505111354
  contributor:
    fullname: Macdonald
– volume: 62
  start-page: 561
  year: 2021
  ident: B148
  article-title: First-in-human evaluation of (18)F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.120.249144
  contributor:
    fullname: Naganawa
– volume: 19
  start-page: 583
  year: 2018
  ident: B75
  article-title: Rodent models for Alzheimer disease.
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/s41583-018-0054-8
  contributor:
    fullname: Götz
– volume: 14
  start-page: 1522
  year: 2018
  ident: B114
  article-title: Molecular imaging in dementia: past, present, and future.
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.jalz.2018.06.2855
  contributor:
    fullname: Laforce
– volume: 13
  year: 2019
  ident: B167
  article-title: Canine cognitive dysfunction and Alzheimer’s disease - two facets of the same disease?
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00604
  contributor:
    fullname: Prpar Mihevc
– volume: 13
  year: 2021
  ident: B15
  article-title: Neuroimaging of Alzheimer’s disease: radiotracers and their utility in clinical research.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.624330
  contributor:
    fullname: Bao
– volume: 40
  start-page: 3491
  year: 2020
  ident: B192
  article-title: Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2880-19.2020
  contributor:
    fullname: Shimojo
– volume: 116
  start-page: 1686
  year: 2019
  ident: B92
  article-title: PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1812155116
  contributor:
    fullname: Horti
– volume: 28
  start-page: 618
  year: 2017
  ident: B151
  article-title: Reduced cortical excitatory synapse number in APOE4 mice is associated with increased calcineurin activity.
  publication-title: Neuroreport
  doi: 10.1097/WNR.0000000000000811
  contributor:
    fullname: Neustadtl
– volume: 11
  year: 2017
  ident: B10
  article-title: Cognitive decline in neuronal aging and Alzheimer’s disease: role of NMDA receptors and associated proteins.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2017.00626
  contributor:
    fullname: Avila
– volume: 41
  start-page: 2410
  year: 2021
  ident: B237
  article-title: PET imaging of colony-stimulating factor 1 receptor: a head-to-head comparison of a novel radioligand.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1177/0271678X211004146
  contributor:
    fullname: Zhou
– volume: 134
  start-page: 1089
  year: 2011
  ident: B70
  article-title: 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease.
  publication-title: Brain
  doi: 10.1093/brain/awr038
  contributor:
    fullname: Fodero-Tavoletti
– volume: 12
  start-page: 998
  year: 2021
  ident: B109
  article-title: In vitro evaluation of [3 H]CPPC as a tool radioligand for CSF-1R.
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.0c00802
  contributor:
    fullname: Knight
– volume: 25
  year: 2020
  ident: B221
  article-title: Characterization of (18)F-PM-PBB3 ((18)F-APN-1607) uptake in the rTg4510 mouse model of tauopathy.
  publication-title: Molecules
  doi: 10.3390/molecules25071750
  contributor:
    fullname: Weng
– volume: 14
  start-page: 1816
  year: 2010
  ident: B106
  article-title: Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease.
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2009.00809.x
  contributor:
    fullname: Kloskowska
– volume: 20
  start-page: 1894
  year: 2003
  ident: B170
  article-title: Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons.
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2003.07.002
  contributor:
    fullname: Rocher
– volume: 62
  start-page: 405
  year: 2010
  ident: B210
  article-title: Glutamate receptor ion channels: structure, regulation, and function.
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.109.002451
  contributor:
    fullname: Traynelis
– volume: 145
  start-page: 45
  year: 2011
  ident: B231
  article-title: Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer’s disease and the brain of aged dogs with cognitive dysfunction.
  publication-title: J. Comp. Pathol.
  doi: 10.1016/j.jcpa.2010.11.004
  contributor:
    fullname: Yu
– volume: 60
  start-page: 559
  year: 2012
  ident: B238
  article-title: APOE genotype alters glial activation and loss of synaptic markers in mice.
  publication-title: Glia
  doi: 10.1002/glia.22289
  contributor:
    fullname: Zhu
– volume: 18
  start-page: 5202
  year: 2010
  ident: B90
  article-title: Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2).
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2010.05.058
  contributor:
    fullname: Horti
– volume: 8
  year: 2013
  ident: B183
  article-title: Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer’s disease.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0069830
  contributor:
    fullname: Sancheti
– volume: 27
  start-page: 211
  year: 2018
  ident: B103
  article-title: Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal.
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddx366
  contributor:
    fullname: Kang
– volume: 20
  year: 2018
  ident: B222
  article-title: The role of APOE and TREM2 in Alzheimer’s disease-current understanding and perspectives.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20010081
  contributor:
    fullname: Wolfe
– volume: 55
  start-page: 1336
  year: 2014
  ident: B220
  article-title: Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.113.136143
  contributor:
    fullname: Warnock
– volume: 46
  start-page: 2077
  year: 2019
  ident: B182
  article-title: [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-019-04399-0
  contributor:
    fullname: Sanabria Bohórquez
– volume: 10
  start-page: 1544
  ident: B122
  article-title: Synthesis and in vivo evaluation of a novel PET radiotracer for imaging of synaptic vesicle glycoprotein 2A (SV2A) in nonhuman primates.
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.8b00526
  contributor:
    fullname: Li
– volume: 10
  year: 2018
  ident: B28
  article-title: Comparison of (18)F-T807 and (18)F-THK5117 PET in a mouse model of tau pathology.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2018.00174
  contributor:
    fullname: Brendel
– volume: 373
  start-page: 523
  year: 1995
  ident: B73
  article-title: Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
  publication-title: Nature
  doi: 10.1038/373523a0
  contributor:
    fullname: Games
– volume: 26
  start-page: 1343
  year: 2006
  ident: B87
  article-title: Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4236-05.2006
  contributor:
    fullname: Heneka
– volume: 57
  start-page: 792
  year: 2016
  ident: B27
  article-title: Small-animal PET Imaging of tau pathology with 18F-THK5117 in 2 transgenic mouse models.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.163493
  contributor:
    fullname: Brendel
– volume: 33
  start-page: 6245
  year: 2013
  ident: B42
  article-title: A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3672-12.2013
  contributor:
    fullname: Cohen
– volume: 293
  start-page: 1491
  year: 2001
  ident: B76
  article-title: Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
  publication-title: Science
  doi: 10.1126/science.1062097
  contributor:
    fullname: Gotz
– volume: 369
  start-page: 488
  year: 1994
  ident: B84
  article-title: Altered microtubule organization in small-calibre axons of mice lacking tau protein.
  publication-title: Nature
  doi: 10.1038/369488a0
  contributor:
    fullname: Harada
– volume: 13
  year: 2021
  ident: B110
  article-title: Uncovering disease mechanisms in a novel mouse model expressing humanized APOEepsilon4 and Trem2*R47H.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.735524
  contributor:
    fullname: Kotredes
– volume: 11
  year: 2021
  ident: B143
  article-title: Longitudinal assessment of tau-associated pathology by (18)F-THK5351 PET imaging: a histological, biochemical, and behavioral Study.
  publication-title: Diagnostics
  doi: 10.3390/diagnostics11101874
  contributor:
    fullname: Moreno-Gonzalez
– volume: 43
  start-page: 325
  year: 2016
  ident: B59
  article-title: [(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
  publication-title: Nucl. Med. Biol.
  doi: 10.1016/j.nucmedbio.2016.03.004
  contributor:
    fullname: Estrada
– volume: 20
  start-page: 76
  year: 2017
  ident: B80
  article-title: Silent allosteric modulation of mGluR5 maintains glutamate signaling while rescuing Alzheimer’s mouse phenotypes.
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.06.023
  contributor:
    fullname: Haas
– volume: 139
  year: 2020
  ident: B119
  article-title: Alzheimer’s disease pathology in APOE transgenic mouse models: the who, what, when, where, why, and how.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2020.104811
  contributor:
    fullname: Lewandowski
– volume: 14
  year: 2016
  ident: B127
  article-title: The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction.
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-0901-1
  contributor:
    fullname: Lo Sasso
– volume: 7
  start-page: 87
  year: 2000
  ident: B53
  article-title: Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes.
  publication-title: Neurobiol. Dis.
  doi: 10.1006/nbdi.1999.0279
  contributor:
    fullname: Duff
– volume: 10
  year: 2013
  ident: B137
  article-title: (3)H-deprenyl and (3)H-PIB autoradiography show different laminar distributions of astroglia and fibrillar beta-amyloid in Alzheimer brain.
  publication-title: J. Neuroinflamm.
  doi: 10.1186/1742-2094-10-90
  contributor:
    fullname: Marutle
– volume: 21
  start-page: 871
  year: 2019
  ident: B19
  article-title: PET imaging of the P2X7 ion channel with a novel tracer.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-018-01313-2
  contributor:
    fullname: Berdyyeva
– volume: 13
  year: 2021
  ident: B117
  article-title: Simple, single-shot phosphoproteomic analysis of heat-stable tau identifies age-related changes in pS235- and pS396-tau levels in non-human primates.
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2021.767322
  contributor:
    fullname: Leslie
– volume: 15
  year: 2016
  ident: B49
  article-title: Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.
  publication-title: Mol. Imaging
  doi: 10.1177/1536012115624920
  contributor:
    fullname: Declercq
– volume: 24
  start-page: 29
  year: 2018
  ident: B85
  article-title: Amyloid-beta plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
  publication-title: Nat. Med.
  doi: 10.1038/nm.4443
  contributor:
    fullname: He
– volume: 100
  start-page: 12462
  year: 2003
  ident: B11
  article-title: Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.2034101100
  contributor:
    fullname: Bacskai
– volume: 13
  start-page: 1034
  year: 2009
  ident: B18
  article-title: The rat as an animal model of Alzheimer’s disease.
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/j.1582-4934.2009.00781.x
  contributor:
    fullname: Benedikz
– volume: 6
  year: 2017
  ident: B46
  article-title: Role of BACE1 in Alzheimer’s synaptic function.
  publication-title: Transl. Neurodegener.
  doi: 10.1186/s40035-017-0093-5
  contributor:
    fullname: Das
– volume: 33
  start-page: 1995
  year: 2012
  ident: B165
  article-title: Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer’s disease.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2011.09.026
  contributor:
    fullname: Poisnel
– volume: 53
  start-page: 1617
  year: 2016
  ident: B99
  article-title: Expression of the Alzheimer’s disease mutations AbetaPP695sw and PSEN1M146I in double-transgenic gottingen minipigs.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-160408
  contributor:
    fullname: Jakobsen
– volume: 55
  start-page: 1537
  year: 2017
  ident: B215
  article-title: Longitudinal characterization of [18F]-FDG and [18F]-AV45 uptake in the double transgenic TASTPM mouse model.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-160760
  contributor:
    fullname: Waldron
– volume: 17
  start-page: 157
  year: 2001
  ident: B101
  article-title: Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.
  publication-title: Biomol. Eng.
  doi: 10.1016/s1389-0344(01)00067-3
  contributor:
    fullname: Jankowsky
– volume: 182
  start-page: 4378
  year: 2009
  ident: B185
  article-title: Activation of microglia by amyloid {beta} requires P2X7 receptor expression.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0803612
  contributor:
    fullname: Sanz
– volume: 7
  ident: B214
  article-title: In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-beta load in aged APPPS1-21 mice.
  publication-title: Alzheimers Res. Ther.
  doi: 10.1186/s13195-015-0158-6
  contributor:
    fullname: Waldron
– volume: 46
  start-page: 1959
  year: 2005
  ident: B130
  article-title: Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
  publication-title: J. Nucl. Med.
  contributor:
    fullname: Lopresti
– volume: 69
  start-page: 475
  year: 2015
  ident: B155
  article-title: Comparing alpha7 nicotinic acetylcholine receptor binding, amyloid-beta deposition, and mitochondria complex-I function in living brain: a PET study in aged monkeys.
  publication-title: Synapse
  doi: 10.1002/syn.21842
  contributor:
    fullname: Nishiyama
– volume: 5
  start-page: 223
  year: 1996
  ident: B34
  article-title: Transgenesis in rats: technical aspects and models.
  publication-title: Transgen. Res.
  doi: 10.1007/BF01972876
  contributor:
    fullname: Charreau
– volume: 25
  start-page: 1528
  year: 2005
  ident: B166
  article-title: Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B.
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/sj.jcbfm.9600146
  contributor:
    fullname: Price
– volume: 3
  start-page: 481
  year: 2017
  ident: B12
  article-title: Measuring brain synaptic vesicle protein 2A with positron emission tomography and [(18)F]UCB-H.
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.trci.2017.08.004
  contributor:
    fullname: Bahri
– volume: 124
  start-page: 47
  year: 2001
  ident: B190
  article-title: Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus.
  publication-title: Behav. Brain Res.
  doi: 10.1016/s0166-4328(01)00232-7
  contributor:
    fullname: Shaw
– volume: 33
  start-page: 1448
  year: 2012
  ident: B65
  article-title: First transgenic rat model developing progressive cortical neurofibrillary tangles.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2010.10.015
  contributor:
    fullname: Filipcik
– volume: 34
  start-page: 1790
  year: 2013
  ident: B173
  article-title: In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2012.12.027
  contributor:
    fullname: Rojas
– volume: 36
  start-page: 1455
  year: 2011
  ident: B229
  article-title: Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.31
  contributor:
    fullname: Yamamoto
– volume: 3
  year: 2015
  ident: B32
  article-title: The domestic cat as a natural animal model of Alzheimer’s disease.
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-015-0258-3
  contributor:
    fullname: Chambers
– volume: 25
  start-page: 277
  year: 2010
  ident: B124
  article-title: A nonhuman primate model of Alzheimer’s disease generated by intracranial injection of amyloid-beta42 and thiorphan.
  publication-title: Metab. Brain Dis.
  doi: 10.1007/s11011-010-9207-9
  contributor:
    fullname: Li
– volume: 39
  start-page: 97
  year: 2019
  ident: B179
  article-title: The new PET tracer F-18-SDM-8 effectively detects reduced SV2a binding in a rodent model of Alzheimer’s disease.
  publication-title: J. Cerebr. Blood F Met.
  contributor:
    fullname: Sadasivam
– volume: 20
  start-page: 113
  year: 2010
  ident: B116
  article-title: A novel transgenic rat model with a full Alzheimer’s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2010-1349
  contributor:
    fullname: Leon
– year: 2021
  ident: B233
  article-title: Comparison of 11 C-Pittsburgh compound-B and 18 F-flutemetamol white matter binding in PET.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.121.263281
  contributor:
    fullname: Zeydan
– volume: 17
  start-page: 688
  ident: B213
  article-title: Preclinical comparison of the amyloid-beta radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in aged APPPS1-21 and BRI1-42 mouse models of cerebral amyloidosis.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-015-0833-9
  contributor:
    fullname: Waldron
– volume: 57
  start-page: 777
  year: 2016
  ident: B147
  article-title: Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.168179
  contributor:
    fullname: Nabulsi
– volume: 37
  start-page: 294
  year: 2010
  ident: B78
  article-title: Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2009.09.004
  contributor:
    fullname: Grueninger
– volume: 59
  start-page: 509
  year: 2018
  ident: B129
  article-title: Neuroinflammation appears early on PET imaging and then plateaus in a mouse model of alzheimer disease.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.117.197608
  contributor:
    fullname: Lopez-Picon
– volume: 9
  year: 2017
  ident: B152
  article-title: Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain.
  publication-title: Alzheimers Res. Ther.
  doi: 10.1186/s13195-017-0253-y
  contributor:
    fullname: Ng
– volume: 16
  year: 2022
  ident: B207
  article-title: PET imaging of synaptic density: challenges and opportunities of synaptic vesicle glycoprotein 2A PET in small animal imaging.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2022.787404
  contributor:
    fullname: Toyonaga
– volume: 84
  start-page: 208
  year: 2019
  ident: B115
  article-title: Age dependency of mGluR5 availability in 5xFAD mice measured by PET.
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2019.08.006
  contributor:
    fullname: Lee
– volume: 51
  start-page: 227
  year: 2016
  ident: B217
  article-title: Alzheimer’s disease neuroimaging, I. Application of the IWG-2 diagnostic criteria for Alzheimer’s disease to the ADNI.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-150824
  contributor:
    fullname: Wang
– volume: 322
  start-page: 223
  year: 2017
  ident: B71
  article-title: Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer’s disease.
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2016.05.012
  contributor:
    fullname: Foster
– volume: 24
  start-page: 1112
  year: 2019
  ident: B118
  article-title: Tau PET imaging in neurodegenerative tauopathies-still a challenge.
  publication-title: Mol. Psychiatry
  doi: 10.1038/s41380-018-0342-8
  contributor:
    fullname: Leuzy
– volume: 59
  start-page: 1869
  year: 2018
  ident: B223
  article-title: Characterization of 3 novel tau radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in healthy controls and in alzheimer subjects.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.209916
  contributor:
    fullname: Wong
– volume: 114
  start-page: 1179
  year: 2001
  ident: B48
  article-title: Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.114.6.1179
  contributor:
    fullname: Dawson
– volume: 4
  start-page: 99
  year: 2010
  ident: B177
  article-title: Correlating familial Alzheimer’s disease gene mutations with clinical phenotype.
  publication-title: Biomark Med.
  doi: 10.2217/bmm.09.92
  contributor:
    fullname: Ryan
– volume: 4
  start-page: 233
  year: 2001
  ident: B29
  article-title: BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.
  publication-title: Nat. Neurosci.
  doi: 10.1038/85064
  contributor:
    fullname: Cai
– volume: 14
  start-page: 1304
  year: 1995
  ident: B77
  article-title: Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1995.tb07116.x
  contributor:
    fullname: Gotz
– volume: 17
  start-page: 933
  year: 2021
  ident: B17
  article-title: A novel tau-based rhesus monkey model of Alzheimer’s pathogenesis.
  publication-title: Alzheimers Dement.
  doi: 10.1002/alz.12318
  contributor:
    fullname: Beckman
– volume: 113
  start-page: 293
  year: 2017
  ident: B62
  article-title: Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [(11)C]ABP688 PET imaging and ex vivo immunoblotting.
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2016.10.009
  contributor:
    fullname: Fang
– volume: 17
  year: 2016
  ident: B142
  article-title: Toxin-induced experimental models of learning and memory impairment.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17091447
  contributor:
    fullname: More
– volume: 12
  start-page: 1885
  year: 2021
  ident: B139
  article-title: Synthesis and assessment of novel probes for imaging tau pathology in transgenic mouse and rat models.
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.0c00790
  contributor:
    fullname: McMurray
– volume: 3
  year: 2015
  ident: B227
  article-title: Murine Abeta over-production produces diffuse and compact Alzheimer-type amyloid deposits.
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-015-0252-9
  contributor:
    fullname: Xu
– volume: 51
  start-page: 253
  year: 2021
  ident: B20
  article-title: Imaging of tau pathology in neurodegenerative diseases: an update.
  publication-title: Semin. Nucl. Med.
  doi: 10.1053/j.semnuclmed.2020.12.004
  contributor:
    fullname: Beyer
– volume: 6
  year: 2019
  ident: B24
  article-title: (18)F-FDG-PET in mouse models of Alzheimer’s disease.
  publication-title: Front. Med.
  doi: 10.3389/fmed.2019.00071
  contributor:
    fullname: Bouter
– volume: 46
  start-page: 2099
  year: 2019
  ident: B79
  article-title: Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-019-04419-z
  contributor:
    fullname: Guehl
– volume: 10
  start-page: 24
  year: 2002
  ident: B194
  article-title: Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
  publication-title: Am. J. Geriatr. Psychiatry
  doi: 10.1097/00019442-200201000-00004
  contributor:
    fullname: Shoghi-Jadid
– volume: 397
  start-page: 1577
  year: 2021
  ident: B186
  article-title: Alzheimer’s disease.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)32205-4
  contributor:
    fullname: Scheltens
– volume: 26
  start-page: 135
  year: 2011
  ident: B193
  article-title: The merits of FDDNP-PET imaging in Alzheimer’s disease.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2011-0008
  contributor:
    fullname: Shin
– volume: 524
  start-page: 874
  year: 2016
  ident: B195
  article-title: Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment.
  publication-title: J. Comp. Neurol.
  doi: 10.1002/cne.23877
  contributor:
    fullname: Smolek
– volume: 17
  start-page: 920
  year: 2021
  ident: B47
  article-title: Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates.
  publication-title: Alzheimers Dement.
  doi: 10.1002/alz.12325
  contributor:
    fullname: Datta
– volume: 7
  year: 2016
  ident: B188
  article-title: Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease.
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10759
  contributor:
    fullname: Sehlin
– volume: 17
  start-page: 115
  ident: B7
  article-title: Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer’s disease.
  publication-title: Alzheimers Dement.
  doi: 10.1002/alz.12192
  contributor:
    fullname: Arnsten
– volume: 2
  year: 2020
  ident: B230
  article-title: M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology.
  publication-title: Brain Commun.
  doi: 10.1093/braincomms/fcaa058
  contributor:
    fullname: Yi
– volume: 23
  start-page: 665
  year: 2021
  ident: B140
  article-title: Pinpointing brain TREM2 levels in two mouse models of Alzheimer’s disease.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-021-01591-3
  contributor:
    fullname: Meier
– volume: 63
  start-page: 2411
  year: 2020
  ident: B205
  article-title: Discovery of [(11)C]MK-6884: a positron emission tomography (PET) imaging agent for the study of M4Muscarinic receptor positive allosteric modulators (PAMs) in neurodegenerative diseases.
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b01406
  contributor:
    fullname: Tong
– volume: 116
  start-page: 26224
  year: 2019
  ident: B83
  article-title: Alzheimer’s disease: a clinical perspective and future nonhuman primate research opportunities.
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1912954116
  contributor:
    fullname: Haque
– volume: 33
  start-page: 3765
  year: 2013
  ident: B141
  article-title: Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4251-12.2013
  contributor:
    fullname: Melnikova
– volume: 9
  year: 2019
  ident: B234
  article-title: Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice.
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-42286-8
  contributor:
    fullname: Zhao
– volume: 12
  year: 2021
  ident: B236
  article-title: PET imaging of neuroinflammation in Alzheimer’s disease.
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.739130
  contributor:
    fullname: Zhou
– volume: 15
  year: 2016
  ident: B50
  article-title: The effects of physiological and methodological determinants on 18F-FDG mouse brain imaging exemplified in a double transgenic alzheimer model.
  publication-title: Mol. Imaging
  doi: 10.1177/1536012115624919
  contributor:
    fullname: Deleye
– volume: 14
  start-page: 2719
  year: 2017
  ident: B16
  article-title: Pharmacokinetic characterization of [(18)F]UCB-H PET radiopharmaceutical in the rat brain.
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.7b00235
  contributor:
    fullname: Becker
– volume: 21
  start-page: 509
  year: 2019
  ident: B45
  article-title: Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers.
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-018-1260-5
  contributor:
    fullname: Constantinescu
– volume: 48
  start-page: 1327
  year: 2021
  ident: B121
  article-title: Assessment of test-retest reproducibility of [(18)F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-020-05149-3
  contributor:
    fullname: Li
– volume: 60
  start-page: 1780
  year: 2019
  ident: B208
  article-title: In vivo synaptic density imaging with (11)C-UCB-J detects treatment effects of saracatinib in a mouse model of alzheimer disease.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.223867
  contributor:
    fullname: Toyonaga
– volume: 11
  start-page: 909
  year: 2009
  ident: B39
  article-title: Transmission and spreading of tauopathy in transgenic mouse brain.
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1901
  contributor:
    fullname: Clavaguera
– volume: 61
  start-page: 1037
  year: 2018
  ident: B96
  article-title: In vivo visualization of tau accumulation, microglial activation, and brain atrophy in a mouse model of tauopathy rTg4510.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-170509
  contributor:
    fullname: Ishikawa
– volume: 78
  start-page: 1345
  year: 2020
  ident: B198
  article-title: Metabotropic glutamate receptors in alzheimer’s disease synaptic dysfunction: therapeutic opportunities and hope for the future.
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-201146
  contributor:
    fullname: Srivastava
– volume: 76
  start-page: 149
  year: 2020
  ident: B200
  article-title: Tau PET imaging with [18F]PM-PBB3 in frontotemporal dementia with MAPT mutation.
  publication-title: J. Alzheimers. Dis.
  doi: 10.3233/JAD-200287
  contributor:
    fullname: Su
– volume: 294
  start-page: 12754
  year: 2019
  ident: B180
  article-title: Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation.
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA119.009487
  contributor:
    fullname: Saito
– volume: 17
  year: 2016
  ident: B125
  article-title: Age- and brain region-specific changes of glucose metabolic disorder, learning, and memory dysfunction in early Alzheimer’s disease assessed in APP/PS1 transgenic mice using (18)F-FDG-PET.
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17101707
  contributor:
    fullname: Li
– volume: 184
  start-page: 881
  year: 2019
  ident: B63
  article-title: High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2018.10.011
  contributor:
    fullname: Fang
– volume: 9
  year: 2019
  ident: B168
  article-title: Nanoscale structure of amyloid-β plaques in Alzheimer’s disease.
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-41443-3
  contributor:
    fullname: Querol-Vilaseca
– volume: 60
  start-page: 1147
  year: 2019
  ident: B146
  article-title: Evaluation of (11)C-LSN3172176 as a novel PET tracer for imaging M1 muscarinic acetylcholine receptors in nonhuman primates.
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.222034
  contributor:
    fullname: Nabulsi
– volume: 47
  start-page: 256
  year: 2020
  ident: B181
  article-title: Brain metabolic signatures across the Alzheimer’s disease spectrum.
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-019-04559-2
  contributor:
    fullname: Sala
– volume: 4
  start-page: 29
  year: 2001
  ident: B211
  article-title: Neurotrophins are required for nerve growth during development.
  publication-title: Nat. Neurosci.
  doi: 10.1038/82868
  contributor:
    fullname: Tucker
– volume: 129
  start-page: 583
  ident: B57
  article-title: Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons.
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2004.07.036
  contributor:
    fullname: Echeverria
– volume: 91
  start-page: e859
  year: 2018
  ident: B9
  article-title: Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000006075
  contributor:
    fullname: Aschenbrenner
– volume: 14
  year: 2020
  ident: B93
  article-title: PET imaging for dynamically monitoring neuroinflammation in APP/PS1 mouse model using.
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2020.00810
  contributor:
    fullname: Hu
– volume: 74
  start-page: 912
  year: 2015
  ident: B187
  article-title: Detection and quantification of beta-amyloid, pyroglutamyl abeta, and tau in aged canines.
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/NEN.0000000000000230
  contributor:
    fullname: Schmidt
– volume: 27
  start-page: 10957
  year: 2007
  ident: B133
  article-title: Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron emission tomography.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0673-07.2007
  contributor:
    fullname: Maeda
– volume: 25
  start-page: 10857
  year: 2005
  ident: B159
  article-title: Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer’s disease.
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1738-05.2005
  contributor:
    fullname: Okamura
– volume: 68
  start-page: 1205
  year: 2007
  ident: B169
  article-title: 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000259035.98480.ed
  contributor:
    fullname: Rabinovici
– volume: 73
  start-page: 83
  year: 2015
  ident: B162
  article-title: Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2014.08.032
  contributor:
    fullname: Peeraer
– volume: 46
  start-page: 1952
  ident: B123
  article-title: Synthesis and in vivo evaluation of [F-18]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A).
  publication-title: Eur. J. Nucl. Med. Mol. I
  doi: 10.1007/s00259-019-04357-w
  contributor:
    fullname: Li
– volume: 86
  start-page: 582
  year: 2003
  ident: B6
  article-title: Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2003.01879.x
  contributor:
    fullname: Andorfer
– volume: 55
  start-page: 1152
  year: 2014
  ident: B30
  article-title: Radiosynthesis and preliminary evaluation of 11C-levetiracetam for PET imaging of SV2A expression.
  publication-title: J. Nucl. Med.
  doi: 10.1021/ml500285t
  contributor:
    fullname: Cai
– volume: 13
  start-page: 159
  year: 2004
  ident: B100
  article-title: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddh019
  contributor:
    fullname: Jankowsky
SSID ssj0062842
Score 2.34166
SecondaryResourceType review_article
Snippet The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for detection of...
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo...
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 872509
SubjectTerms Alzheimer’s disease
neurodegeneration
Neuroscience
positron emission tomography
SV2A
tau
β-amyloid (Aβ)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7iyYuo9bG-iCAehNV95XWsWlFB8WChtyXZTehCm4qPg578G_49f4mTpC2tCF687iYkfJPNzLczfIPQoeKVAOpDwQJwgguVqljJWsSsrjh4qzTRPnt-e0evusVNj_RmWn25mrAgDxyAO1Ws0vAx89Tkrl2WkCwl3FBRJxJcswyhUSImZCrcwRQu3SzkMIGCiVNjG-u0ubPshDNw-mLOC3mx_t8izJ-FkjOe53IFLY9DRtwOW11FC9quoVbbAl0evuEj7Is4_d_xFiL3nQd8PfSth3Bjcds2Q5jrOp4NnvHI4Pbgva-boX76-vh8xhchPbOOupedh_OreNwZIa5ynoiYMpMorYBtkEoacDKGCU1ppUye1gYoTZ4SQFs5kc9ak5xSrgrgNrJmRDEIMjbQoh1ZvYWwguFJJWsFvKwguZaANZUZreoi4UKqCB1PkCofgwBGCcTBwVp6WEsHaxlgjdCZw3I60GlX-wdg0XJs0fIvi0boYGKJEs66S2BIq0evsBKwGyBcQBsjtBksM10qJ5QToAoRYnM2m9vL_Bvb9L2eNjDWNGfF9n9sfgctOTxcfUFW7KLFl6dXvQdhy4va9yf0G1kE6gk
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RuPRSlUfbtBQZCRWpUmgSP3Oo0PISVAL1wErcIjuxIdKut90FqfDrGTu7qy7aA9fEieMZ2998nskMwJ5RdYnUR6AGcAYzk5vU6KZMZVMrRKs8s9F7fnklzvvs1w2_WYFZeaupACdLqV2oJ9UfDw7-_X08xAX_MzBOxNsfzrc-ZN4uigMlEdLLN7BWMCTqIZKPzZ0KAnfi6PwU4UchtNQ7J-fyVyzAVMzmv8wEfRlJ-R80nb2Hd1ObkvS6SbAOK9ZvwGbPI58ePpJvJEZ5xuPzTaC_T6_JxTDWJiKtJz3fDvHZUBJtMCEjR3qDpzvbDu14f0JOOu_NFvTPTq-Pz9Np4YS0piorUyFdZqzBIfJaO8QgJ0srRG0czRuHjIfmHJVhQg7QxnIqhDIMqY9uJDcSbZAPsOpH3n4CYrB5VuvGIG1jnFqN4CZ0IeqGZarUJoHvMzlVf7r8GBXyiiDUKgq1CkKtOqEmcBQkOW8YUlvHC6PxbTVdKZWRtcXdW-WOhvpopZY5V06UTabRFtM6gd2ZHipcCsG_ob0dPWBPSH6QjyGrTOBjp5d5V5QLxZFJJCAXNLbwLYt3fHsX020joc2pZJ9f0e8XeBuGG6ILCrYNq_fjB_sVjZZ7sxOn4jPJ1Ogj
  priority: 102
  providerName: Scholars Portal
Title PET Imaging in Animal Models of Alzheimer's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/35685772
https://search.proquest.com/docview/2675606026
https://pubmed.ncbi.nlm.nih.gov/PMC9171374
https://doaj.org/article/b7ce46781f354419a7158f69d0a251aa
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4Bp14qHn2El1yp6gEpu3n5kePyKq20iANIe4tsx4ZIGy9a4ACn_o3-PX4JY2eDuhUnLj4ktux8M_LMlxmPAb4roUukPgwlgBpcqFTFStZlzGst0FqliQnR8_E5O7sqfk_oZAVofxYmJO1r1QzctB245ibkVt62etjniQ0vxkdIMdKcF8NVWEUF7Sl6t_0y3G9DiJP540Doj3ehTGRi5dC6xvkS3Vk2EBxtvy8ZmlMmKOfZkl0K5fvf8jn_T538xxadrsPHhRNJRt1iN2DFuE3YGjkk0O0j-UFCWmf4X74F9OLkkvxqw2VEpHFk5JoWx_o70KZ3ZGbJaPp0Y5rWzJ___L0jx13A5hNcnZ5cHp3Fi7sSYp2LpIwZt4kyCr-XamnR7FheGsa0snlaWyQ5eUoRf-XLftaG5owJVSDbkTWniqPb8RnW3MyZr0AUdk-0rBUytYLmRqI9YzJjui4SUUoVwUGPVHXblcSokEp4hKuAcOURrjqEIzj0WL529NWsw4PZ_LpayLRSXBvcsEVqc38lWil5SoVlZZ1IdL-kjOBbL4kKtd-HNKQzswecCfkOUjAkkhF86STzOlUv2Qj4ksyW1rL8BhUuVNheKNj2u0fuwAcPgk8zyIpdWLufP5g99F7u1X5g_dj-nKTYjguxH_T3BVnI78c
link.rule.ids 230,315,730,783,787,867,888,2109,24330,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VcoALf4USoGAkxAEp2fzZTo7b0moL3aqHLerNsh2HRmy81Xb3QE-8Bq_XJ-nY2VRsxQWusS0n89me-TLjGYAPqtAlUh-GCOAKzlWiQiWrMuSVLlBbJbHx3vPxMRud5l_O6NkG0P4ujA_a16qJ7LSNbHPuYysvWj3o48QGJ-M9pBhJxvPBPbiP-zXOe5LeHcAMT1zv5GTuQhBa5J0zE7lYOahtY12S7jSNCo7a3yUNzSgrKOfpmmbyCfz_ZnXeDZ78QxsdPIZv_Xd0QSg_ouVCRfrqTorHf_7QJ_BoZZ-SYdf8FDaMfQZbQ4vcvP1JPhIfMep_xW8BPdmfkMPW1zkijSVD27Q41pVXm16SWU2G06tz07Rmfv3r9yX53PmCnsPpwf5kbxSuyjCEGoVbhozXsTIKBUm1rFGj1bw0jGlVZ0lVI3_KEorQKpdRtDI0Y6xQORIpWXGqOFo0L2DTzqx5CURh91jLSiEJzGlmJKpKJlOmqzwuSqkC-NRDIC66bBsCWYqDTnjohINOdNAFsOtAuu3oEmX7B7P5d7GSolBcG9QFRVJnrtpaKXlCi5qVVSzRspMygPc9xAI3lvOWSGtmS5wJqRSyO-SoAWx3kN9O1S-ZAPjaYlh7l_UWhNgn715B-uq_R76DB6PJ-EgcHR5_fQ0PnUBcNEOav4HNxXxpdtBIWqi3fkvcAHU7Dww
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkRAXXoUSnkZCHJDyju3kuLRdtUCrPbRSxSWyHZtGbLyr7e6Bnvgb_D1-CWNnU3UrTr0mtpz4sz3zZSbfAHyQpaqQ-jBEAFdwIVMZStFUIW9UidYqTbSPnh8ds4PT4ssZPbtW6ssn7SvZRnbaRbY997mV807FQ55YPDnaRYqR5ryI542J78I93LMJG4h6fwgzPHV9oJO5n4LQK-8DmsjHqtjY1jqh7iyLSo4egBMOzSkrKefZhnXyIv7_8zxvJlBes0jjR_B9eJc-EeVntFrKSF3ekHm81cs-hodrP5WM-iZP4I62T2F7ZJGjd7_IR-IzR_0n-W2gk_0Tctj5ekektWRk2w77ujJr0wsyM2Q0vTzXbacXf3__uSB7fUzoGZyO9092D8J1OYZQ4QRXIeMmkVriZFIlDFo2wyvNmJImTxuDPCpPKUIsnbJoo2nOWCkLJFSi4VRy9Gyew5adWf0CiMTmiRKNRDJY0FwLNJlMZEw1RVJWQgbwaYChnveqGzWyFQdf7eGrHXx1D18Anx1QVw2dYLa_MFv8qNczWUuuNNqEMjW5q7pWCZ7S0rCqSQR6eEIE8H6AucYN5qImwurZCkdCSoUsD7lqADs97FdDDcsmAL6xIDaeZfMOwuxFvNewvrx1z3dwf7I3rr8dHn99BQ_cfLikhqx4DVvLxUq_QV9pKd_6XfEPAi0RjA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET+Imaging+in+Animal+Models+of+Alzheimer%27s+Disease&rft.jtitle=Frontiers+in+neuroscience&rft.au=Chen%2C+Baosheng&rft.au=Marquez-Nostra%2C+Bernadette&rft.au=Belitzky%2C+Erika&rft.au=Toyonaga%2C+Takuya&rft.date=2022-05-24&rft.issn=1662-4548&rft.volume=16&rft.spage=872509&rft.epage=872509&rft_id=info:doi/10.3389%2Ffnins.2022.872509&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-4548&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-4548&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-4548&client=summon